Organization Description
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with therapies derived from a deep understanding of the plasma proteome in aging and disease.
Related News
November 12, 2020
A team of researchers, including Dr. Tony Wyss-Coray, co-founder of Alkahest, has discovered that exposing young cells to aged blood makes their gene expression like old cells. Signaling cells to act older We have known from the heterochronic parabiosis and plasmapheresis research performed by Dr. Irina Conboy's lab and similar work done by Dr. Wyss-Coray's...
